Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS, Revenue Beat Expectations
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.27 --0%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
CAN, UNFI, SUNB, More
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 adjusted EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $213 million versus the consensus estimate of $208.98 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
